Patents by Inventor Silvia RAVERA

Silvia RAVERA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic application of (Boc)-creatine
    Patent number: 9700539
    Abstract: A creatine derivative, (Boc)2-creatine, is used as a medicament, in particular in a therapeutic antitumor treatment. I (Boc)2-creatine.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: July 11, 2017
    Assignee: UNIVERSITA' DEGLI STUDI DI GENOVA
    Inventors: Patrizia Garbati, Maurizio Balestrino, Enrico Adriano, Silvia Ravera, Enrico Millo, Gianluca Damonte, Annalisa Salis
  • THERAPEUTIC APPLICATION OF (BOC)2-CREATINE
    Publication number: 20170000757
    Abstract: A creatine derivative, (Boc)2-creatine, is used as a medicament, in particular in a therapeutic antitumor treatment. I (Boc)2-creatine.
    Type: Application
    Filed: December 23, 2014
    Publication date: January 5, 2017
    Inventors: Patrizia GARBATI, Maurizio BALESTRINO, Enrico ADRIANO, Silvia RAVERA, Enrico MILLO, Gianluca DAMONTE, Annalisa SALIS